Cargando…
Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894195/ https://www.ncbi.nlm.nih.gov/pubmed/33614511 http://dx.doi.org/10.3389/fonc.2020.637880 |
| _version_ | 1783653197989019648 |
|---|---|
| author | Ranieri, Girolamo Laface, Carmelo Laforgia, Mariarita De Summa, Simona Porcelli, Mariangela Macina, Francesco Ammendola, Michele Molinari, Pasquale Lauletta, Gianfranco Di Palo, Alessandra Rubini, Giuseppe Ferrari, Cristina Gadaleta, Cosmo Damiano |
| author_facet | Ranieri, Girolamo Laface, Carmelo Laforgia, Mariarita De Summa, Simona Porcelli, Mariangela Macina, Francesco Ammendola, Michele Molinari, Pasquale Lauletta, Gianfranco Di Palo, Alessandra Rubini, Giuseppe Ferrari, Cristina Gadaleta, Cosmo Damiano |
| author_sort | Ranieri, Girolamo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7894195 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78941952021-02-20 Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study Ranieri, Girolamo Laface, Carmelo Laforgia, Mariarita De Summa, Simona Porcelli, Mariangela Macina, Francesco Ammendola, Michele Molinari, Pasquale Lauletta, Gianfranco Di Palo, Alessandra Rubini, Giuseppe Ferrari, Cristina Gadaleta, Cosmo Damiano Front Oncol Oncology Frontiers Media S.A. 2021-02-05 /pmc/articles/PMC7894195/ /pubmed/33614511 http://dx.doi.org/10.3389/fonc.2020.637880 Text en Copyright © 2021 Ranieri, Laface, Laforgia, De Summa, Porcelli, Macina, Ammendola, Molinari, Lauletta, Di Palo, Rubini, Ferrari and Gadaleta http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Ranieri, Girolamo Laface, Carmelo Laforgia, Mariarita De Summa, Simona Porcelli, Mariangela Macina, Francesco Ammendola, Michele Molinari, Pasquale Lauletta, Gianfranco Di Palo, Alessandra Rubini, Giuseppe Ferrari, Cristina Gadaleta, Cosmo Damiano Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study |
| title | Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study |
| title_full | Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study |
| title_fullStr | Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study |
| title_full_unstemmed | Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study |
| title_short | Corrigendum: Bevacizumab Plus FOLFOX-4 Combined With Deep Electro-Hyperthermia as First-line Therapy in Metastatic Colon Cancer: A Pilot Study |
| title_sort | corrigendum: bevacizumab plus folfox-4 combined with deep electro-hyperthermia as first-line therapy in metastatic colon cancer: a pilot study |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894195/ https://www.ncbi.nlm.nih.gov/pubmed/33614511 http://dx.doi.org/10.3389/fonc.2020.637880 |
| work_keys_str_mv | AT ranierigirolamo corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT lafacecarmelo corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT laforgiamariarita corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT desummasimona corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT porcellimariangela corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT macinafrancesco corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT ammendolamichele corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT molinaripasquale corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT laulettagianfranco corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT dipaloalessandra corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT rubinigiuseppe corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT ferraricristina corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy AT gadaletacosmodamiano corrigendumbevacizumabplusfolfox4combinedwithdeepelectrohyperthermiaasfirstlinetherapyinmetastaticcoloncancerapilotstudy |